APA (7th ed.) Citation

Matthaios Papadimitriou-Olivgeris, Christina Bartzavali, Alexandra Nikolopoulou, Fevronia Kolonitsiou, Virginia Mplani, Iris Spiliopoulou, . . . Markos Marangos. (2020). Impact of Tigecycline's MIC in the Outcome of Critically Ill Patients with Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Bacteraemia Treated with Tigecycline Monotherapy-Validation of 2019's EUCAST Proposed Breakpoint Changes. MDPI AG.

Chicago Style (17th ed.) Citation

Matthaios Papadimitriou-Olivgeris, Christina Bartzavali, Alexandra Nikolopoulou, Fevronia Kolonitsiou, Virginia Mplani, Iris Spiliopoulou, Myrto Christofidou, Fotini Fligou, and Markos Marangos. Impact of Tigecycline's MIC in the Outcome of Critically Ill Patients with Carbapenemase-Producing <i>Klebsiella Pneumoniae</i> Bacteraemia Treated with Tigecycline Monotherapy-Validation of 2019's EUCAST Proposed Breakpoint Changes. MDPI AG, 2020.

MLA (9th ed.) Citation

Matthaios Papadimitriou-Olivgeris, et al. Impact of Tigecycline's MIC in the Outcome of Critically Ill Patients with Carbapenemase-Producing <i>Klebsiella Pneumoniae</i> Bacteraemia Treated with Tigecycline Monotherapy-Validation of 2019's EUCAST Proposed Breakpoint Changes. MDPI AG, 2020.